Minerva Neurosciences, Inc - Common Stock —— 季度资产负债表 (NASDAQ:NERV) | MetaTrader

展开完整图表完整图表

新闻

All You Need to Know About Minerva Neurosciences (NERV) Rating Upgrade to Buy

Minerva Neurosciences (NERV) Loses 37.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

H.C. Wainwright上调Minerva Neurosciences目标价,看好试验设计

H.C. Wainwright raises Minerva Neurosciences price target on trial design

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript

明瑞神经科学公司任命精神分裂症专家加入董事会

Minerva Neurosciences appoints schizophrenia expert to board of directors

美国股市涨跌不一；截至收盘道琼斯工业平均指数上涨0.47%

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences (NASDAQ:NERV)

Minerva Neurosciences股价飙升，获得2亿美元融资

Minerva Neurosciences stock soars after securing $200 million financing